Ontology highlight
ABSTRACT: Objectives
Most biomarker studies of sepsis originate from high-income countries, whereas mortality risk is higher in low- and middle-income countries. The second version of the Pediatric Sepsis Biomarker Risk Model (PERSEVERE-II) has been validated in multiple North American PICUs for prognosis. Given differences in epidemiology, we assessed the performance of PERSEVERE-II in septic children from Pakistan, a low-middle income country. Due to uncertainty regarding how well PERSEVERE-II would perform, we also assessed the utility of other select biomarkers reflecting endotheliopathy, coagulopathy, and lung injury.Design
Prospective cohort study.Setting
PICU in Aga Khan University Hospital in Karachi, Pakistan.Patients
Children (< 18 yr old) meeting pediatric
SUBMITTER: Ishaque S
PROVIDER: S-EPMC10317305 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature